Clinical Trials Browser

Cholangiocarcinoma × dexamethasone 21-phosphate × Clear all

NCT04251715 2025-04-18

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma